IL4 and cancer: Recently, it has been shown that anti-inflammatory cytokines (IL-10 and IL-4) are protective against CIPN [15, 43]; however, systemic use of IL-10 in general has had poor clinical outcomes [44] as it can promote the progression of cancer [45] and propagate chronic viral infections [46].